ArticlePloS one2022

Bedaquiline-based treatment for extensively drug-resistant tuberculosis in South Africa: A cost-effectiveness analysis.

Ginenus Fekadu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.